Adder­all sup­ply woes con­tin­ue as the FDA con­firms short­age of im­me­di­ate re­lease cap­sules

While it’s been on­ly a few days since more man­u­fac­tur­ers of gener­ic Adder­all cap­sules an­nounced up­com­ing short­ages, the FDA is al­so rais­ing con­cerns on the is­sue.

The reg­u­la­tor an­nounced that there was a short­age of the im­me­di­ate re­lease ver­sion of the gener­ic, which treats AD­HD and nar­colep­sy.

In a state­ment, the FDA said it is in com­mu­ni­ca­tion with all man­u­fac­tur­ers, with Te­va re­port­ing to the agency that it is ex­pe­ri­enc­ing “on­go­ing in­ter­mit­tent man­u­fac­tur­ing de­lays.” The FDA es­ti­mates that some prod­ucts will re­turn to stock this month, but some won’t be on the mar­ket un­til No­vem­ber or De­cem­ber.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN